Go Pro

WELL Health Technologies (WELL) Competitors

WELL Health Technologies logo
C$4.31 +0.13 (+3.11%)
As of 07/3/2026 04:00 PM Eastern

WELL vs. PSA, GC, LB, CBL, and AGF.B

Should you buy WELL Health Technologies stock or one of its competitors? MarketBeat compares WELL Health Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with WELL Health Technologies include Purpose High Interest Savings Fund (PSA), Great Canadian Gaming (GC), Laurentian Bank of Canada (LB), Callidus Capital (CBL), and AGF Management (AGF.B). These companies are all part of the "trading" industry.

How does WELL Health Technologies compare to Purpose High Interest Savings Fund?

WELL Health Technologies (TSE:WELL) and Purpose High Interest Savings Fund (TSE:PSA) are both trading companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

In the previous week, WELL Health Technologies' average media sentiment score of 0.00 equaled Purpose High Interest Savings Fund'saverage media sentiment score.

Company Overall Sentiment
WELL Health Technologies Neutral
Purpose High Interest Savings Fund Neutral

5.1% of WELL Health Technologies shares are owned by institutional investors. 6.8% of WELL Health Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

WELL Health Technologies has a net margin of 1.82% compared to Purpose High Interest Savings Fund's net margin of 0.00%. WELL Health Technologies' return on equity of 3.15% beat Purpose High Interest Savings Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
WELL Health Technologies1.82% 3.15% 2.07%
Purpose High Interest Savings Fund N/A N/A N/A

WELL Health Technologies presently has a consensus price target of C$6.92, suggesting a potential upside of 60.48%. Given WELL Health Technologies' stronger consensus rating and higher possible upside, analysts clearly believe WELL Health Technologies is more favorable than Purpose High Interest Savings Fund.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WELL Health Technologies
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Purpose High Interest Savings Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

WELL Health Technologies has higher revenue and earnings than Purpose High Interest Savings Fund.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WELL Health TechnologiesC$1.47B0.75C$73.76MC$0.1139.18
Purpose High Interest Savings FundN/AN/AN/AN/AN/A

Summary

WELL Health Technologies beats Purpose High Interest Savings Fund on 9 of the 9 factors compared between the two stocks.

How does WELL Health Technologies compare to Great Canadian Gaming?

WELL Health Technologies (TSE:WELL) and Great Canadian Gaming (TSE:GC) are both trading companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

WELL Health Technologies has a net margin of 1.82% compared to Great Canadian Gaming's net margin of 0.00%. WELL Health Technologies' return on equity of 3.15% beat Great Canadian Gaming's return on equity.

Company Net Margins Return on Equity Return on Assets
WELL Health Technologies1.82% 3.15% 2.07%
Great Canadian Gaming N/A N/A N/A

5.1% of WELL Health Technologies shares are owned by institutional investors. 6.8% of WELL Health Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

WELL Health Technologies currently has a consensus target price of C$6.92, suggesting a potential upside of 60.48%. Given WELL Health Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe WELL Health Technologies is more favorable than Great Canadian Gaming.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WELL Health Technologies
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Great Canadian Gaming
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, WELL Health Technologies' average media sentiment score of 0.00 equaled Great Canadian Gaming'saverage media sentiment score.

Company Overall Sentiment
WELL Health Technologies Neutral
Great Canadian Gaming Neutral

WELL Health Technologies has higher revenue and earnings than Great Canadian Gaming. Great Canadian Gaming is trading at a lower price-to-earnings ratio than WELL Health Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WELL Health TechnologiesC$1.47B0.75C$73.76MC$0.1139.18
Great Canadian GamingC$228.70M0.00-C$121.82M-C$2.11N/A

Summary

WELL Health Technologies beats Great Canadian Gaming on 12 of the 12 factors compared between the two stocks.

How does WELL Health Technologies compare to Laurentian Bank of Canada?

Laurentian Bank of Canada (TSE:LB) and WELL Health Technologies (TSE:WELL) are both small-cap trading companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends.

13.6% of Laurentian Bank of Canada shares are held by institutional investors. Comparatively, 5.1% of WELL Health Technologies shares are held by institutional investors. 0.1% of Laurentian Bank of Canada shares are held by company insiders. Comparatively, 6.8% of WELL Health Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Laurentian Bank of Canada had 1 more articles in the media than WELL Health Technologies. MarketBeat recorded 1 mentions for Laurentian Bank of Canada and 0 mentions for WELL Health Technologies. Laurentian Bank of Canada's average media sentiment score of 0.00 equaled WELL Health Technologies'average media sentiment score.

Company Overall Sentiment
Laurentian Bank of Canada Neutral
WELL Health Technologies Neutral

WELL Health Technologies has higher revenue and earnings than Laurentian Bank of Canada. WELL Health Technologies is trading at a lower price-to-earnings ratio than Laurentian Bank of Canada, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Laurentian Bank of CanadaC$956.73M1.88-C$5.52MC$0.31129.45
WELL Health TechnologiesC$1.47B0.75C$73.76MC$0.1139.18

WELL Health Technologies has a net margin of 1.82% compared to Laurentian Bank of Canada's net margin of 1.36%. WELL Health Technologies' return on equity of 3.15% beat Laurentian Bank of Canada's return on equity.

Company Net Margins Return on Equity Return on Assets
Laurentian Bank of Canada1.36% 1.01% -0.03%
WELL Health Technologies 1.82%3.15%2.07%

Laurentian Bank of Canada currently has a consensus price target of C$36.44, suggesting a potential downside of 9.20%. WELL Health Technologies has a consensus price target of C$6.92, suggesting a potential upside of 60.48%. Given WELL Health Technologies' stronger consensus rating and higher probable upside, analysts clearly believe WELL Health Technologies is more favorable than Laurentian Bank of Canada.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Laurentian Bank of Canada
2 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
WELL Health Technologies
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Laurentian Bank of Canada has a beta of 1.238538, indicating that its stock price is 24% more volatile than the broader market. Comparatively, WELL Health Technologies has a beta of 0.900556, indicating that its stock price is 10% less volatile than the broader market.

Summary

WELL Health Technologies beats Laurentian Bank of Canada on 9 of the 15 factors compared between the two stocks.

How does WELL Health Technologies compare to Callidus Capital?

Callidus Capital (TSE:CBL) and WELL Health Technologies (TSE:WELL) are both small-cap trading companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, media sentiment, earnings and valuation.

WELL Health Technologies has higher revenue and earnings than Callidus Capital. Callidus Capital is trading at a lower price-to-earnings ratio than WELL Health Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Callidus CapitalC$181.78M0.02-C$639K-C$4.26N/A
WELL Health TechnologiesC$1.47B0.75C$73.76MC$0.1139.18

WELL Health Technologies has a net margin of 1.82% compared to Callidus Capital's net margin of 0.00%. WELL Health Technologies' return on equity of 3.15% beat Callidus Capital's return on equity.

Company Net Margins Return on Equity Return on Assets
Callidus CapitalN/A N/A N/A
WELL Health Technologies 1.82%3.15%2.07%

86.8% of Callidus Capital shares are owned by institutional investors. Comparatively, 5.1% of WELL Health Technologies shares are owned by institutional investors. 6.8% of WELL Health Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

WELL Health Technologies has a consensus target price of C$6.92, indicating a potential upside of 60.48%. Given WELL Health Technologies' stronger consensus rating and higher possible upside, analysts plainly believe WELL Health Technologies is more favorable than Callidus Capital.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Callidus Capital
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
WELL Health Technologies
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Callidus Capital's average media sentiment score of 0.00 equaled WELL Health Technologies'average media sentiment score.

Company Overall Sentiment
Callidus Capital Neutral
WELL Health Technologies Neutral

Callidus Capital has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, WELL Health Technologies has a beta of 0.900556, meaning that its stock price is 10% less volatile than the broader market.

Summary

WELL Health Technologies beats Callidus Capital on 13 of the 14 factors compared between the two stocks.

How does WELL Health Technologies compare to AGF Management?

AGF Management (TSE:AGF.B) and WELL Health Technologies (TSE:WELL) are both small-cap trading companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

AGF Management presently has a consensus price target of C$20.28, indicating a potential upside of 0.35%. WELL Health Technologies has a consensus price target of C$6.92, indicating a potential upside of 60.48%. Given WELL Health Technologies' stronger consensus rating and higher probable upside, analysts clearly believe WELL Health Technologies is more favorable than AGF Management.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AGF Management
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63
WELL Health Technologies
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

16.2% of AGF Management shares are owned by institutional investors. Comparatively, 5.1% of WELL Health Technologies shares are owned by institutional investors. 18.7% of AGF Management shares are owned by company insiders. Comparatively, 6.8% of WELL Health Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, AGF Management had 1 more articles in the media than WELL Health Technologies. MarketBeat recorded 1 mentions for AGF Management and 0 mentions for WELL Health Technologies. AGF Management's average media sentiment score of 0.57 beat WELL Health Technologies' score of 0.00 indicating that AGF Management is being referred to more favorably in the media.

Company Overall Sentiment
AGF Management Positive
WELL Health Technologies Neutral

AGF Management has higher earnings, but lower revenue than WELL Health Technologies. AGF Management is trading at a lower price-to-earnings ratio than WELL Health Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AGF ManagementC$575.66M2.23C$85.73MC$2.079.76
WELL Health TechnologiesC$1.47B0.75C$73.76MC$0.1139.18

AGF Management has a beta of 1.309741, meaning that its stock price is 31% more volatile than the broader market. Comparatively, WELL Health Technologies has a beta of 0.900556, meaning that its stock price is 10% less volatile than the broader market.

AGF Management has a net margin of 16.58% compared to WELL Health Technologies' net margin of 1.82%. AGF Management's return on equity of 7.64% beat WELL Health Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
AGF Management16.58% 7.64% 5.20%
WELL Health Technologies 1.82%3.15%2.07%

Summary

AGF Management beats WELL Health Technologies on 12 of the 16 factors compared between the two stocks.

Get WELL Health Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for WELL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WELL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WELL vs. The Competition

MetricWELL Health TechnologiesMedical Care Facilities IndustryMedical SectorTSE Exchange
Market CapC$1.07BC$1.56BC$7.18BC$13.07B
Dividend YieldN/A3.91%2.67%6.18%
P/E Ratio39.1813.2328.0236.51
Price / Sales0.7517.83532.5910.34
Price / Cash12.277.9049.2682.29
Price / Book1.051.8810.964.52
Net IncomeC$73.76MC$63.03MC$3.57BC$299.09M
7 Day Performance4.36%-0.88%2.12%1.85%
1 Month Performance-10.95%0.05%5.25%1.71%
1 Year Performance1.41%12.62%33.29%36.40%

WELL Health Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WELL
WELL Health Technologies
1.8118 of 5 stars
C$4.31
+3.1%
C$6.92
+60.5%
+1.4%C$1.07BC$1.47B39.18510
PSA
Purpose High Interest Savings Fund
N/AC$50.02
flat
N/A0.0%C$3.06BN/AN/A5,900
GC
Great Canadian Gaming
N/AN/AN/AN/AC$2.59BC$228.70MN/A7,900
LB
Laurentian Bank of Canada
0.59 of 5 stars
C$40.19
-0.9%
C$36.44
-9.3%
+29.5%C$1.80BC$956.73M129.653,000
CBL
Callidus Capital
N/AC$25.16
+0.4%
N/AN/AC$1.44BC$181.78MN/A460

Related Companies and Tools


This page (TSE:WELL) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners